Targeting NF-kappa B Signaling by Artesunate Restores Sensitivity of Castrate-Resistant Prostate Cancer Cells to Antiandrogens

Targeting NF-kappa B Signaling by Artesunate Restores Sensitivity of Castrate-Resistant Prostate Cancer Cells to Antiandrogens

Androgen deprivation therapy (ADT) is the most preferred treatment for men with metastatic prostate cancer (PCa). However, the disease eventually progresses and develops resistance to ADT in majority of the patients, leading to the emergence of metastatic castration-resistant prostate cancer (mCRPC)...

Full description

Bibliographic Details
Main Authors: Jessica J. Nunes, Swaroop K. Pandey, Anjali Yadav, Sakshi Goel, Bushra Ateeq
Format: Article
Language:English
Published: Elsevier 2017-04-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S147655861630358X

Internet

http://www.sciencedirect.com/science/article/pii/S147655861630358X

Similar Items